The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54) |
93.394, 93.395 |
RFA-CA-17-032 |
| Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) |
93.213 |
PA-18-323 |
| Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) |
93.213 |
PA-18-322 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
93.855 |
PAR-18-319 |
| BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865 |
RFA-EB-17-005 |
| Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp) |
93.084, 93.113, 93.121, 93.172, 93.173, 93.242, 93.262, 93.273, 93.279, 93.350, 93.394, 93.395, 93.847, 93.853, 93.855, 93.865, 93.866 |
PA-18-314 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) |
93.394 |
PAR-18-317 |
| Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) |
93.213, 93.273, 93.279, 93.393, 93.866 |
PAR-18-307 |
| Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) |
93.353 |
RFA-CA-17-047 |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) |
93.113, 93.121, 93.353, 93.853 |
RFA-CA-17-046 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed |
93.394 |
PAR-18-310 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) |
93.121, 93.395 |
PAR-18-313 |
| Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01) |
93.113, 93.121, 93.273, 93.353, 93.853 |
RFA-CA-17-045 |
| Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) |
93.307, 93.353 |
RFA-CA-17-048 |
| Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) |
93.213, 93.273, 93.279, 93.307, 93.393, 93.865, 93.866 |
PAR-17-306 |
| Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28) |
93.273 |
PAR-17-305 |
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) - (Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-18-025 |
| National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) |
93.859 |
PAR-17-341 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20 - Clinical Trials Not Allowed) |
93.847 |
RFA-DK-17-033 |
| Collaborative Research in Computational Neuroscience |
47.041, 47.049, 47.070, 47.074, 47.075, 47.079, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.866, 93.867 |
18-501 |
| BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EB-17-004 |
| BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EB-17-003 |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.313, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-18-010 |
| BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 - Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.313, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-18-009 |
| Women's HIV/AIDS Cohort Study (WHCS ) (R01) |
93.121, 93.865 |
RFA-HD-18-018 |
| Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 - Clinical Trial Not Allowed) |
93.859 |
PAR-18-403 |
| Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 - Clinical Trial Not Allowed) |
93.859 |
PAR-18-402 |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396 |
PAR-18-303 |
| NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) |
93.837, 93.838, 93.839, 93.853 |
PAR-18-304 |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) |
93.113, 93.242, 93.273, 93.279, 93.307, 93.393 |
PAR-17-496 |
| Research to Improve Native American Health (R21 Clinical Trial Optional) |
93.113, 93.242, 93.273, 93.279, 93.307, 93.393 |
PAR-17-464 |
| Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) |
93.394, 93.395 |
PA-17-495 |
| NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00) |
93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.361, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-18-007 |
| NCI Outstanding Investigator Award (R35) |
93.393 |
PAR-17-494 |
| Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional) |
93.866 |
RFA-AG-18-013 |
| BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.313, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-18-008 |
| Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional) |
93.361 |
PA-17-493 |
| Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional) |
93.307, 93.361 |
PAR-17-490 |
| Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional) |
93.307, 93.361 |
PAR-17-491 |
| Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-18-014 |
Search Results 5201-5240 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
